Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Apr 13:6:96.
doi: 10.1186/1471-2458-6-96.

Evaluation of a decision aid for prenatal testing of fetal abnormalities: a cluster randomised trial [ISRCTN22532458]

Affiliations

Evaluation of a decision aid for prenatal testing of fetal abnormalities: a cluster randomised trial [ISRCTN22532458]

Cate Nagle et al. BMC Public Health. .

Abstract

Background: By providing information on the relative merits and potential harms of the options available and a framework to clarify preferences, decision aids can improve knowledge and realistic expectations and decrease decisional conflict in individuals facing decisions between alternative forms of action. Decision-making about prenatal testing for fetal abnormalities is often confusing and difficult for women and the effectiveness of decision aids in this field has not been established. This study aims to test whether a decision aid for prenatal testing of fetal abnormalities, when compared to a pamphlet, improves women's informed decision-making and decreases decisional conflict.

Methods/design: A cluster designed randomised controlled trial is being conducted in Victoria, Australia. Fifty General Practitioners (GPs) have been randomised to one of two arms: providing women with either a decision aid or a pamphlet. The two primary outcomes will be measured by comparing the difference in percentages of women identified as making an informed choice and the difference in mean decisional conflict scores between the two groups. Data will be collected from women using questionnaires at 14 weeks and 24 weeks gestation. The sample size of 159 women in both arms of the trial has been calculated to detect a difference of 18% (50 to 68%) in informed choice between the two groups. The required numbers have been adjusted to accommodate the cluster design, miscarriage and participant lost--to--follow up. Baseline characteristics of women will be summarised for both arms of the trial. Similarly, characteristics of GPs will be compared between arms. Differences in the primary outcomes will be analysed using 'intention-to-treat' principles. Appropriate regression techniques will adjust for the effects of clustering and include covariates to adjust for the stratifying variable and major potential confounding factors.

Discussion: The findings from this trial will make a significant contribution to improving women's experience of prenatal testing and will have application to a variety of maternity care settings. The evaluation of a tailored decision aid will also have implications for pregnancy care providers by identifying whether or not such a resource will support their role in providing prenatal testing information.

PubMed Disclaimer

References

    1. Johnson J, Summers A. Prenatal Genetic Screening for Down Syndrome and Open Neural Tube Defects using Maternal Serum Marker Screening. SOGC Clinical Practice Guidelines. 1999.
    1. Royal Australian and New Zealand College of Obstetricians and Human Genetics Society of Australasia Joint HGSA/RANZCOG recommended ' Best Practice' Guidelines on antenatal screening for Down syndrome and other fetal aneuploidy. 2004.
    1. Royal College of Obstetricians and Gynaecologists . Antenatal screening for Down syndrome. London, Royal College of Obstetricians and Gynaecologists, available online: www.rcog.org.uk/resources/Public/pdf/Down_syndrome_Screening.pdf; 2003.
    1. Jaques AM, Halliday JL, Bell RJ. Do women know that prenatal testing detects fetuses with Down syndrome? Journal of Obstetrics and Gynaecology. 2004;24:647–651. - PubMed
    1. De Vigan C, Vodovar V, Goujard J, Garel M, Vayssiere C, Goffinet F. Mothers' knowledge of screening for trisomy 21 in 1999: a survey in Paris maternity units. Eur J Obstet Gynecol Reprod Biol. 2002;104:14–20. doi: 10.1016/S0301-2115(01)00559-0. - DOI - PubMed

Publication types

Associated data